43 related articles for article (PubMed ID: 21766447)
1. Design, synthesis, and biological evaluation of novel benzo[6,7]indolo[3,4-c]isoquinolines as anticancer agents with topoisomerase I inhibition.
Sakai K; Soshima T; Hirose Y; Ishibashi F; Hirao S
Bioorg Med Chem Lett; 2024 May; 104():129710. PubMed ID: 38518997
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel PEG-conjugated 20(S)-camptothecin sulfonylamidine derivatives with potent in vitro antitumor activity via Cu-catalyzed three-component reaction.
Song ZL; Chen HL; Wang YH; Goto M; Gao WJ; Cheng PL; Morris-Natschke SL; Liu YQ; Zhu GX; Wang MJ; Lee KH
Bioorg Med Chem Lett; 2015 Jul; 25(13):2690-3. PubMed ID: 25987370
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and potent cytotoxic activity of novel 7-(N-[(substituted-sulfonyl)piperazinyl]-methyl)-camptothecin derivatives.
Zhu GX; Cheng PL; Goto M; Zhang N; Morris-Natschke SL; Hsieh KY; Yang GZ; Yang QR; Liu YQ; Chen HL; Zhang XS; Lee KH
Bioorg Med Chem Lett; 2017 Apr; 27(8):1750-1753. PubMed ID: 28285912
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, cytotoxic activity and molecular docking studies of new 20(S)-sulfonylamidine camptothecin derivatives.
Song ZL; Wang MJ; Li L; Wu D; Wang YH; Yan LT; Morris-Natschke SL; Liu YQ; Zhao YL; Wang CY; Liu H; Goto M; Liu H; Zhu GX; Lee KH
Eur J Med Chem; 2016 Jun; 115():109-20. PubMed ID: 26994847
[TBL] [Abstract][Full Text] [Related]
5. The antitumor activity of CYB-L10, a human topoisomerase IB catalytic inhibitor.
Yu Q; Chen Y; Yang H; Zhang HL; Agama K; Pommier Y; An LK
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):818-822. PubMed ID: 30907213
[TBL] [Abstract][Full Text] [Related]
6. A novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2/M phase cell cycle arrest to K562 cells.
Wu N; Wu XW; Agama K; Pommier Y; Du J; Li D; Gu LQ; Huang ZS; An LK
Biochemistry; 2010 Nov; 49(47):10131-6. PubMed ID: 21033700
[TBL] [Abstract][Full Text] [Related]
7. Natural Compounds as Therapeutic Agents: The Case of Human Topoisomerase IB.
Ottaviani A; Iacovelli F; Fiorani P; Desideri A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923641
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological evaluation of harmine derivatives as topoisomerase I inhibitors for cancer treatment.
Guo YL; Yu JW; Cao Y; Cheng KX; Dong-Zhi SN; Zhang YF; Ren QJ; Yin Y; Li CL
Eur J Med Chem; 2024 Feb; 265():116061. PubMed ID: 38154256
[TBL] [Abstract][Full Text] [Related]
9. 12-Substituted 2,3-dimethoxy-8,9-methylenedioxybenzo[i]phenanthridines as novel topoisomerase I-targeting antitumor agents.
Feng W; Satyanarayana M; Tsai YC; Liu AA; Liu LF; LaVoie EJ
Bioorg Med Chem; 2009 Apr; 17(7):2877-85. PubMed ID: 19303306
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Biological Activity of a New Indenoisoquinoline Copper Derivative as a Topoisomerase I Inhibitor.
Molinaro C; Wambang N; Pellegrini S; Henry N; Lensink MF; Germain E; Bousquet T; de Ruyck J; Cailliau K; Pélinski L; Martoriati A
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834037
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of new homocamptothecin analogs.
Luo Y; Yu S; Tong L; Huang Q; Lu W; Chen Y
Eur J Med Chem; 2012 Aug; 54():281-6. PubMed ID: 22647222
[TBL] [Abstract][Full Text] [Related]
12. An overview on the development of new potentially active camptothecin analogs against cancer.
Chazin Ede L; Reis Rda R; Junior WT; Moor LF; Vasconcelos TR
Mini Rev Med Chem; 2014; 14(12):953-62. PubMed ID: 25355593
[TBL] [Abstract][Full Text] [Related]
13. Trastuzumab Deruxtecan: First Approval.
Keam SJ
Drugs; 2020 Apr; 80(5):501-508. PubMed ID: 32144719
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 9-(heteroarylmethylidene)amino derivatives of homocamptothecin with biological activities.
Guo W; Miao Z; Sheng C; Yao J; Liu W; Zhu L; Zhang Y; Cheng P; Dong G; Zhuang C; Zhang W
Chem Biodivers; 2011 Jul; 8(7):1266-73. PubMed ID: 21766447
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of novel 7-acyl homocamptothecins as Topoisomerase I inhibitors.
Liu W; Zhu L; Guo W; Zhuang C; Zhang Y; Sheng C; Cheng P; Yao J; Wang W; Dong G; Wang S; Miao Z; Zhang W
Eur J Med Chem; 2011 Jun; 46(6):2408-14. PubMed ID: 21463912
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 7-alkenyl homocamptothecins as potent topoisomerase I inhibitors.
Zhu L; Zhang X; Lei N; Liu W; Miao Z; Zhuang C; Sheng C; Guo W; Dong G; Yao J; Cheng P; Zhang W
Chem Biodivers; 2012 Jun; 9(6):1084-94. PubMed ID: 22700227
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]